Highlights Finanziari
Significant improvement in profitability, supported by a new organizational model and the transition towards higher value-added business
2025 was a year of profound transformation, confirming our long-term vision. To achieve the goal of creating sustainable value through a model for the adoption of AI across the business ecosystem, we have invested over the years in building capabilities and assets capable of interpreting and solving the market’s needs for innovation and efficiency". Stated Fabrizio Milano d'Aragona, CEO of Datrix. "Now, following a necessary internal reorganization and a stronger focus on higher value-added activities, the expected results are here to come. The addition of two new senior management positions, the Group General Manager and the CFO, has allowed us to embed a managerial culture into the organization combining vision with execution capabilities. The reorganization of subsidiary Adapex around a 100% AI-Driven business model has brought the Group efforts to a business with significantly stronger potential and materially higher margins. The consolidation of Aramix’s and Bytek’s expertise has led to gradual transition of their value proposition from a project-oriented to a product-oriented approach. The end market has matured and is increasingly seeking solutions to be implemented on a stable basis rather than on an experimental one. This helps the Group enhance its technological expertise and knowledge base through a relation with clients measurable by the results actually achieved by adopting vertical, rather than generalist, Artificial Intelligence solutions." commented Fabrizio Milano d'Aragona, Datrix CEO
FY 2025 Financial Highlights
13,6
Revenues
60%
Recurring Revenues
1,8
EBITDA
Performance
Per area di business
AI for Data Monetization (85% of total business lines revenues) recorded revenues of approximately €11.1 million compared to €16.0 million in FY2024. The AdTech segment (Adapex) generated revenues of approximately €5.4 million (€10.2 million in FY2024). The MarTech segment (ByTek) reported revenues of approximately €5.7 million (€5.8 million in FY2024). The selective discontinuation of low-margin legacy activities within the AdTech segment and the repositioning towards a publisher-centric, AI-powered model led to a complete reorganization of the managerial structure, enabling the development of a new growth plan focused on premium publishers. Within the MarTech segment, a progressive transition was undertaken from traditional digital mediamarketing services towards intelligence activities based on the proprietary prediction platform,repositioning ByTek as an AI-product-native business. The ByTek Prediction Platform is consolidating its position in the enterprise segment, representing a strategic proprietary asset, now certified and listed on Google Cloud Platform. These decisions impacted revenue generation during the second half of 2025, while at the same time clearly directing future growth objectives based on more sophisticated, 100% AI-driven models, which
ensure a leading positioning for the Group’s companies in their respective areas of operation.
AI for Industrial & Business Processes (15% of total business lines revenues) recorded revenues of approximately €2.0 million compared to €1.8 million in FY2024. The development of deep-tech solutions in the Industry 5.0 and energy efficiency segments continues, strengthening positioning in the high-value vertical applications field. Furthermore, the Group is consolidating its role as a reference player in high-impact innovative projects, as confirmed by the award to Aramix, acting as lead partner, of the RENDITA project dedicated to the energy transition and the digitalisation of networks, which confirms the Group's ability to develop proprietary technological platforms in strategic areas for the resilience and efficiency of energy systems. The award as lead partner of the BETTER project represented the Group’s first step into the Healthcare market, where - through Aramix - the Group is 3 able to capitalise on its expertise and translate it into solutions adoptable by hospitals, research centres and healthcare operators.